Navigation Links
Only Severely Depressed Benefit From Antidepressants: Study
Date:2/27/2008

But some mental-health experts dispute the findings

TUESDAY, Feb. 26 (HealthDay News) -- While popular antidepressants such as Prozac are widely prescribed for people with varying degrees of depression, the drugs are only effective for those with the most severe depression, a new study suggests.

"Although patients get better when they take antidepressants, they also get better when they take a placebo, and the difference in improvement is not very great," lead researcher Irving Kirsch, a professor of psychology at the University of Hull in Great Britain, said in a prepared statement. "This means that depressed people can improve without chemical treatments," he added.

In the study, Kirsch and his colleagues collected data on 35 clinical trials of drugs called selective serotonin reuptake inhibitors, or SSRIs, whose results had been submitted to the U.S. Food and Drug Administration. The antidepressants included in the trials were fluoxetine (Prozac), venlafaxine (Effexor), nefazodone (Serzone), and paroxetine (Seroxat/Paxil).

An analysis of the data showed that patients taking antidepressants fared no better than patients receiving a placebo. This appeared to be the case whether the patients were mildly or moderately depressed.

The drugs only seemed to benefit a small group of patients -- those with the severest depression when the study began.

Based on these results, there appears to be little reason to prescribe these antidepressants to anyone but the most severely depressed patients, the study authors concluded.

The findings were published online Feb. 25 in the journal PLoS Medicine.

Dr. Nada Stotland, president-elect of the American Psychiatric Association, said she wasn't surprised that the study found that not every antidepressant works for every patient. Many people who are depressed don't respond to the first antidepressant they try. It can take up to an average of three different antidepressants until one works for a particular patient, she said.

"Medication helps some, but not all, people with depression," Stotland said in a prepared statement. "For people with mild to moderate depression, psychotherapy can work as well as medication. Studies have shown that between 70 and 80 percent of people can and do get better with a combination of treatment approaches, which will often include individual therapy, family therapy and/or medication.

"Therefore, testing any single antidepressant on a group of depressed individuals will show that many of them do not improve," Stotland added. "There is a small group of depressed individuals who do not respond to any antidepressant."

The new study highlights the fact that treatment for depression needs to be tailored to an individual, and that the most effective treatment will often include multiple approaches, Stotland said. The study results also suggest that more long-term follow-up trials are needed to determine which patients are most likely to benefit from specific therapies.

"Some of the most exciting research in progress at the present time concerns our attempt to match the antidepressant to the patient from the outset; we may be able to perform laboratory tests or identify clinical factors that let us know in advance which antidepressant will work for each person," Stotland said. "That will be an enormous advance for the millions of people suffering from this very painful and potentially disabling disease."

More information

To learn more about antidepressants, visit the U.S. National Library of Medicine.



SOURCES: American Psychiatric Association, news release, Feb. 26, 2008; PLoS Medicine, Feb. 25, 2008, online


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Weight Loss Surgery May Help Less Severely Obese
2. 10th Anniversary of Revolutionary Teaching Approach that Offers the Severely Disabled the Gift of Self-Expression - Through Painting
3. New Hope for Depressed Teens
4. Optimal band imaging with endoscopy facilitates the diagnosis of depressed-type early gastric cancer
5. Why some depressed girls cant smell the roses
6. Possible genetic predictor for response to lithium augmentation in depressed patients
7. Depressed Moms Kids at Higher Injury Risk
8. Drug Plus Psychotherapy Best Treatment for Depressed Teens
9. Kaiser Permanente Study Shows One in Seven Women are Depressed Before, During, or After Pregnancy
10. Treatment Programs Benefit Depressed Workers
11. Are too many people diagnosed as depressed?
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Only Severely Depressed Benefit From Antidepressants: Study
(Date:3/30/2017)... ... March 30, 2017 , ... According to the American Society of Plastic Surgeons ... among the top 5 most popular minimally-invasive cosmetic procedures in the country. With summer ... performed over the next 8-10 weeks. For anyone considering a hair removal procedure, there ...
(Date:3/30/2017)... ... March 30, 2017 , ... AudioEducator, a leader in training ... Readmissions Through Discharge Planning ” with noted expert Sue Dill Calloway, RN, MSN, ... strategies to prevent readmissions in light of the most recent programs at the ...
(Date:3/29/2017)... (PRWEB) , ... March 29, 2017 , ... ... and women’s professional squash, announced it has enlisted New York City-based sports and ... agency will develop and procure sponsorship opportunities for the Professional Squash Association (PSA), ...
(Date:3/29/2017)... (PRWEB) , ... March 30, 2017 , ... Sublime Naturals ... "Spice of Life" or "Wonder Spice", it has been used for thousands of years. ... the East," says Heshelow, author of " Turmeric: How to Use it For Your ...
(Date:3/29/2017)... ... March 29, 2017 , ... Based ... into the challenges employers face in trying to balance both short-term and long-term ... programs? Adding to the growing complexity, companies are finding that the short-term ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... , March 29, 2017  Novartis announced today ... has accepted the company,s Biologics License Application (BLA) ... an investigational chimeric antigen receptor T cell (CAR-T) ... young adult patients with B-cell acute lymphoblastic leukemia ... Novartis for a CAR-T. The priority review designation ...
(Date:3/29/2017)... Research and Markets has announced the addition of the "South ... & Forecast" report to their offering. ... The South Korean Proton Therapy Market is expected to ... Untapped Proton Therapy Market for South Korea was ... Proton Therapy plays an important role in delivering comprehensive cancer care to ...
(Date:3/29/2017)... 29, 2017  Zynex (OTCQB: ZYXI), an innovative medical technology ... medical devices for pain management, stroke rehabilitation, cardiac monitoring ... the Company,s 2016 full-year investor webcast on Monday, April 3, ... The Company expects to file its 2016 full year ... ...
Breaking Medicine Technology: